Positions

Overview

  • Dr. Jodie Dionne-Odom is an Associate Professor in the Division of Infectious Diseases, Chief of Women's Health at the 1917 HIV Clinic, and the Associate Director of Global Health in the Center for Women's Reproductive Health. As a physician-scientist, she designs clinical trials to identify new ways to treat and prevent infectious diseases in women and pregnancy.

    Dr. Dionne has a longstanding committment to advancing women's health in the US and in Africa. Current research projects focus on preventing malaria, sexually transmitted infections and hepatitis B among pregnant women in Cameroon in Central Africa. Over the past 15 years, she has also led or supported HIV/STI research projects in Zambia, Rwanda, Haiti and Peru. In the United States, Dr. Dionne is a member of the CDC/HRSA advisory committee on HIV, Viral Hepatitis and STD Prevention and Treatment, the COVID-19 Taskforce for the American Society of Reproductive Medicine, and the Alabama Maternal Mortality Committee. Dr. Dionne also serves as a research mentor for many students and trainees with projects in women's health.

    • Selected Publications

    Academic Article

    Year Title Altmetric
    2021 The Impact of Epidemiology on Prenatal and Fertility Care during the COVID-19 Pandemic..  American Journal of Epidemiology.  2021
    2021 Limited Utility of Reverse Algorithm Syphilis Testing in HIV Clinic among Men who have Sex with Men..  Sexually Transmitted Diseases.  2021
    2021 Chlamydia Prevalence by Age and Correlates of Infection among Pregnant Women.  Sexually Transmitted Diseases.  48:37-41. 2021
    2021 Factors associated with syphilis seroprevalence in women with and at-risk for HIV infection in the Women's Interagency HIV Study (1994-2015).  Sexually Transmitted Infections.  2021
    2020 Prevalence of and Factors Associated with Genital and Extragenital Chlamydia and Gonorrhea among Transgender Women in HIV Care in the United States; 2005-2016..  Sexually Transmitted Diseases.  2020
    2020 High rates of persistent and recurrent chlamydia in pregnant women after treatment with azithromycin. 2020
    2020 Intersecting Epidemics: Incident Syphilis and Drug Use in Women Living with Human Immunodeficiency Virus in the United States (2005-2016).  Clinical Infectious Diseases.  71:2405-2413. 2020
    2020 Cervicitis: Balancing the Goals of Empiric Therapy and Antimicrobial Stewardship to Improve Women's Health.  Sexually Transmitted Diseases.  47:387-388. 2020
    2020 Heart Failure with Preserved Ejection Fraction in a Postpartum Patient with Superimposed Preeclampsia and COVID-19.  American Journal of Perinatology Reports.  10:E165-E168. 2020
    2020 Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon.  Malaria Journal.  19. 2020
    2020 Performance of 4 Molecular Assays for Detection of Chlamydia and Gonorrhea in a Sample of Human Immunodeficiency Virus-Positive Men Who Have Sex With Men..  Sexually Transmitted Diseases.  47:158-161. 2020
    2019 A comparative analysis of documented contraceptive use among women aged 18–30 living with and without HIV in Alabama.  Contraception.  100:275-278. 2019
    2019 Miscarriage among women in the United States Women's Interagency HIV Study, 1994–2017.  American Journal of Obstetrics and Gynecology.  221:347.e1-347.e13. 2019
    2019 Prevalence of group B streptococcus anogenital colonization and feasibility of an intrapartum screening and antibiotic prophylaxis protocol in Cameroon, Africa 2019
    2019 Erectile Dysfunction Medication Prescription: STI and Risk Behavior in Men with HIV 2019
    2019 HIV Status and Contraceptive Utilization among Women in Cameroon.  Journal of the International Association of Providers of AIDS Care.  18. 2019
    2019 HIV status and other risk factors for prevalent and incident sexually transmitted infection during pregnancy (2000-2014) 2019
    2018 Sexually Transmitted Infection Prevalence in Women with HIV: Is There a Role for Targeted Screening?.  Sexually Transmitted Diseases.  45:762-769. 2018
    2018 Large Outbreak of Hepatitis C Virus Associated with Drug Diversion by a Healthcare Technician.  Clinical Infectious Diseases.  67:845-853. 2018
    2018 Elimination of Vertical Transmission of Hepatitis B in Africa: A Review of Available Tools and New Opportunities 2018
    2018 A decision analytic model for prevention of hepatitis B virus infection in Sub-Saharan Africa using birth-dose vaccination 2018
    2018 High prevalence of multidrug-resistant mycoplasma genitalium in human immunodeficiency virus-infected men who have sex with men in Alabama.  Clinical Infectious Diseases.  66:796-798. 2018
    2018 Hepatitis B virus contact disclosure and testing in Lusaka, Zambia: A mixed-methods study.  BMJ Open.  8. 2018
    2018 Predictors of Infant Hepatitis B Immunization in Cameroon: Data to Inform Implementation of a Hepatitis B Birth Dose 2018
    2017 Predictors of the use of interventions to prevent malaria in pregnancy in Cameroon.  Malaria Journal.  16. 2017
    2016 #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission.  American Journal of Obstetrics and Gynecology.  214:6-14. 2016
    2016 Factors associated with PMTCT cascade completion in four african countries.  AIDS Research and Treatment.  2016. 2016
    2016 Hepatitis B, HIV, and Syphilis Seroprevalence in Pregnant Women and Blood Donors in Cameroon 2016
    2016 Retention in Care among HIV-Infected Pregnant Women in Haiti with PMTCT Option B.  AIDS Research and Treatment.  2016. 2016
    2015 Normal T-cell activation in elite controllers with preserved CD4 + T-cell counts.  AIDS.  29:2245-2254. 2015
    2015 Law and the public’s health: Taken to court: Defending public health authority to access medical records during an outbreak investigation.  Public Health Reports.  130:278-283. 2015
    2015 Taken to court: defending public health authority to access medical records during an outbreak investigation..  Public Health Reports.  130:278-283. 2015
    2015 Preventing vertical transmission of hepatitis B: Guidance on management of pregnant patients with acute and chronic infection.  Contemporary OB/GYN.  60:44-50. 2015
    2014 Adapting and implementing a community program to improve retention in care among patients with hiv in southern haiti: "Group of 6".  AIDS Research and Treatment.  2014. 2014
    2014 Performance of the OraQuick HCV rapid antibody test for screening exposed patients in a hepatitis c outbreak investigation.  Journal of Clinical Microbiology.  52:2650-2652. 2014
    2013 Fungal infections associated with contaminated methylprednisolone injections..  New England Journal of Medicine.  369:1598-1609. 2013
    2013 Reply to Yang et al.  Clinical Infectious Diseases.  57:1212-1213. 2013
    2013 Syphilis treatment response among HIV-discordant couples in Zambia and Rwanda.  Clinical Infectious Diseases.  56:1829-1837. 2013
    2013 Decrease in varicella incidence after implementation of the 2-dose recommendation for varicella vaccine in New Hampshire 2013
    2012 Exposure to nitrogen dioxide in an indoor ice arena - New Hampshire, 2011.  MMWR : Morbidity & Mortality Weekly Report.  61:139-142. 2012
    2011 Antimicrobial resistant gonorrhea in Atlanta: 1988-2006.  Sexually Transmitted Diseases.  38:780-782. 2011
    2010 Gastrointestinal anthrax after an animal-hide drumming event - New Hampshire and Massachusetts, 2009..  MMWR : Morbidity & Mortality Weekly Report.  59:872-877. 2010
    2009 Acute hepatitis C and HIV coinfection.  Lancet Infectious Diseases.  9:775-783. 2009
    2007 Posaconazole treatment for Apophysomyces elegans rhino-orbital zygomycosis following trauma for a male with well-controlled diabetes.  Journal of Clinical Microbiology.  45:1648-1651. 2007

    Chapter

    Year Title Altmetric
    2017 Pituitary abscess: An uncommon condition requiring multidisciplinary care.  423-431. 2017
    2012 Tick-borne Illness 2012
    2009 Access to culturally competent care for patients living with HIV/AIDS.  69-82. 2009

    Research Overview

  • Dr. Dionne's research focus is to optimize the prevention and treatment of infections in women and pregnancy. Current studies test novel regimens to prevent malaria and STI in pregnant women with HIV (PREMISE Trial) and perinatal hepatitis B transmission (REVERT-B Trial) with support from NIH/NICHD and strong collaboration between UAB and scientists at the University of Buea in Cameroon. Clinical trials are conducted by a robust and growing Cameroon Health Initiative Team (CHI UAB) with dedicated study staff who enroll participants at four busy research sites within a national hospital network system.

    Dr. Dionne also leads UAB research efforts as part of the NIAID-supported STI Clinical Trials Group with studies of promising new prevention options for gonorrhea (meningococcal group B vaccine), comparative treatment options for syphilis, and a new oral medication option for the treatment of gonorrhea (zoliflodacin). She is also a Principal Investigator of the NIH MACS/WIHS Combined Cohort Study which actively follows >4,000 women and men living with HIV to improve health outcomes.

    • Principal Investigator On

    Investigator On

  • UAB-MISS MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS)  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2019 - 2026
  • 75N93019F00131 TA02 TO9 Development of a Protocol, Clinical Trial Implementation, Closeout and Analysis of a Phase 2 Clinical Trial to Evaluate the Eficacy of rMenB+OMV NZ (Bexsero, GSK) in Preventing Neisseria Gonorrhoese Infection  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2022
  • 75N93019F00132 TA1 TO15 Overall Administrative and Support Activities for the STI CTG to Include Procedures to Identify, Discuss, and Develop Scientific Concepts  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2022
  • Sexually Transmitted Infections Clinical Trials Group (STI CTG)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2022
  • T013 HHSN27200012 TA1 TO11 Overall Admin and Support Activities for the STI CTG to Include Procedures to Identify, Discuss and Develop Scientific Concepts  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2022
  • T016 HHSN27200014 TA2 TO8 A Phase III Comparative Trial of Benzathine Penicillin G, 2.4 Million Units Administered as a Single Dose Versus Three Sucessive Weekly Doses for Treatment of Early Syphilis in Persons with and without HIV  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2019 - 2022
  • Private Grant  awarded by GlaxoSmithKline 2014 - 2022
  • Private Grant  awarded by Gilead Sciences 2016 - 2022
  • Private Grant  awarded by VIIV HEALTHCARE COMPANY 2016 - 2021
  • Private Grant  awarded by ORACLE CORPORATION 2018 - 2021
  • Private Grant  awarded by VIIV HEALTHCARE COMPANY 2016 - 2021
  • Private Grant  awarded by MERCK & COMPANY, INC. 2017 - 2021
  • Rectal and Oropharyngeal Swabs to Diagnose Gonococcal and Chlamydial Infection in Men and Women  awarded by University of California, San Francisco 2018 - 2021
  • Private Grant  awarded by Gilead Sciences 2016 - 2019
  • Private Grant  awarded by VIIV HEALTHCARE COMPANY 2016 - 2018
  • AIDS Clinical Trials Group: Protocol Funds FTE Funding  awarded by Brigham and Women's Hospital 2014 - 2018
  • Private Grant  awarded by Gilead Sciences 2015 - 2018
  • Private Grant  awarded by Gilead Sciences 2014 - 2017
  • Private Grant  awarded by ROCHE DIAGNOSTICS OPERATIONS INC 2014 - 2015
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2014 - 2015

    • Teaching Overview

  • Dr. Dionne is a highly-rated teacher, mentor and public speaker about infectious diseases. She teaches medical students, housestaff, and graduate students about HIV, sexually transmitted infections, and women's health.

    • Education And Training

  • New York University Medicine, Chief Resident 2006
  • Doctor of Medicine, Dartmouth College 2002
  • Bachelor of Arts in Biology, University of Rochester 1998
  • New York University School of Medicine Medicine, Internship 2003
  • New York University Medicine, Residency 2005
  • Emory University Medicine, Postdoctoral Fellowship 2009
  • National Institutes of Health, Postdoctoral Fellowship 2009

    • Full Name

  • Jodie Dionne-Odom